DGIST Develops Precision Assembly Technology for Key Drug Scaffolds

Researchers at the Daegu Gyeongbuk Institute of Science and Technology (DGIST) have developed a new catalytic technology capable of assembling the structural frameworks of bioactive compounds exclusively in a specific mirror-image form. This precision assembly focuses on the synthesis of beta-methylene carbonyl derivatives, which serve as core scaffolds for numerous pharmaceuticals.

The development, led by Professor Sangwon Seo of the Department of Physics and Chemistry, addresses a critical challenge in pharmaceutical chemistry: enantioselective synthesis. This process allows scientists to produce only one of two possible mirror-image isomers, ensuring the resulting molecule has the precise three-dimensional structure required for biological activity.

The Challenge of Mirror-Image Isomers

In chemistry, certain molecules exist as non-superimposable mirror images of one another, known as mirror-image isomers or enantiomers. While these molecules share the same atomic composition, their different spatial arrangements can lead to vastly different biological outcomes.

This distinction is vital because human proteins are composed of amino acids that exist in only one specific mirror-image configuration. The stereochemistry of a drug molecule determines how it interacts with the body. One enantiomer may provide the intended therapeutic effect, while its mirror counterpart could be inactive or even toxic, potentially causing severe side effects.

Nickel-Based Catalytic Innovation

To achieve this precision, Professor Seo’s team utilized a nickel (Ni) catalyst. Nickel is an abundant and inexpensive transition metal, making it a cost-effective alternative to the expensive noble metals typically used in such high-precision chemical synthesis.

The research team designed a synthesis pathway that allows alkynes to react directly with carbonyl compounds through this specialized nickel catalyst system. This method enables the production of beta-methylene carbonyl derivatives as single enantiomers without the need for the complex auxiliary substances or strong bases that often limit existing synthesis methods.

The team also utilized computer calculations to investigate the mechanism of the catalyst, ensuring the assembly process remains precise, and elaborative.

Industry Implications and Applications

The ability to selectively synthesize the effective configuration of a molecular scaffold is considered a core challenge in the development of new drugs. Because beta-methylene carbonyl derivatives are widely found in natural products and various drug candidates, this technology is expected to have a significant impact on the pharmaceutical industry.

The potential applications of this precision assembly technology include:

• Accelerating the development of new pharmaceutical compounds by simplifying the creation of key scaffolds.
• Reducing the risk of side effects by eliminating the production of inactive or toxic mirror-image isomers.
• Lowering production costs in the high-value-added fine chemical industry by replacing noble metals with abundant nickel.
• Improving the efficiency of synthesizing bioactive substances used in precision chemistry.

By providing a more accessible and precise way to build these molecular backbones, the DGIST research offers a scalable pathway for creating complex bioactive compounds that were previously constrained by difficult process requirements.